Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China · Delayed Price · Currency is CNY 19.51
+0.06 (0.31%)
Apr 29, 2026, 3:00 PM CST
SHA:688553 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.95 | -30.55 | 325.39 | 139.79 | 248.99 | 445.86 |
Depreciation & Amortization | 91.41 | 91.41 | 79.03 | 63.88 | 53.11 | 41.13 |
Other Amortization | 0.92 | 0.92 | 1.73 | 0.71 | - | - |
Loss (Gain) From Sale of Assets | -0 | -0 | 0.3 | - | - | -0 |
Asset Writedown & Restructuring Costs | 172.53 | 172.53 | 9.58 | - | 0.03 | 6.84 |
Loss (Gain) From Sale of Investments | -0.48 | -0.48 | -253.67 | -40.62 | -45.22 | -19 |
Provision & Write-off of Bad Debts | - | - | -0.04 | 2.87 | 1.64 | - |
Other Operating Activities | -23.11 | 6.78 | 8.11 | 6.26 | 11.31 | 2.17 |
Change in Accounts Receivable | -41.96 | -41.96 | -20.27 | -23.94 | -41.61 | -23.86 |
Change in Inventory | -110.2 | -110.2 | -12.88 | 10.56 | 8.95 | -87.04 |
Change in Accounts Payable | 36.12 | 36.12 | 73.37 | -72.57 | -27.16 | 73.54 |
Change in Other Net Operating Assets | 1.29 | 1.29 | 1.98 | 3.91 | -1.57 | 10.83 |
Operating Cash Flow | 108.12 | 90.51 | 242.96 | 66.93 | 194.06 | 446.36 |
Operating Cash Flow Growth | -53.41% | -62.74% | 262.98% | -65.51% | -56.52% | 15.06% |
Capital Expenditures | -80.14 | -105.27 | -128.18 | -296.72 | -461.61 | -433.45 |
Sale of Property, Plant & Equipment | 0.3 | 0.3 | 0.1 | 0.04 | - | 0 |
Investment in Securities | 305.89 | 195.17 | 377.98 | 494.17 | 238 | -1,439 |
Other Investing Activities | 47.08 | 40.59 | 20.55 | 35.86 | 42.58 | - |
Investing Cash Flow | 273.13 | 130.79 | 270.46 | 233.35 | -181.03 | -1,872 |
Short-Term Debt Issued | - | - | 656.39 | 484.9 | 45 | 15.05 |
Long-Term Debt Issued | - | 493.15 | - | - | 12.45 | 1.1 |
Total Debt Issued | 620.95 | 493.15 | 656.39 | 484.9 | 57.45 | 16.15 |
Short-Term Debt Repaid | - | - | -496.5 | -106.47 | -13.2 | -1 |
Long-Term Debt Repaid | - | -385.1 | -3.04 | -7.02 | -54.08 | -21.24 |
Total Debt Repaid | -301 | -385.1 | -499.54 | -113.48 | -67.28 | -22.24 |
Net Debt Issued (Repaid) | 319.95 | 108.05 | 156.86 | 371.42 | -9.83 | -6.08 |
Issuance of Common Stock | - | - | - | - | - | 2,373 |
Repurchase of Common Stock | - | - | -30.02 | - | - | - |
Common Dividends Paid | -199.46 | -199.07 | -98.14 | -98.12 | -90.16 | -0.69 |
Other Financing Activities | 121.77 | 190.97 | -115 | -151 | - | -19.23 |
Financing Cash Flow | 242.26 | 99.95 | -86.3 | 122.3 | -99.99 | 2,347 |
Foreign Exchange Rate Adjustments | -2.54 | -0.73 | 0.07 | 1.64 | -0.16 | -0.04 |
Net Cash Flow | 620.96 | 320.52 | 427.18 | 424.22 | -87.12 | 921.45 |
Free Cash Flow | 27.98 | -14.76 | 114.78 | -229.79 | -267.55 | 12.91 |
Free Cash Flow Growth | -77.79% | - | - | - | - | -94.36% |
Free Cash Flow Margin | 2.72% | -1.48% | 10.49% | -24.79% | -17.92% | 0.71% |
Free Cash Flow Per Share | 0.07 | -0.04 | 0.27 | -0.54 | -0.63 | 0.04 |
Cash Income Tax Paid | 14.9 | 21.11 | 38.68 | 16.83 | 65.76 | 88.39 |
Levered Free Cash Flow | -14.43 | -107.36 | 52.32 | -265.69 | -350.12 | -147.17 |
Unlevered Free Cash Flow | -14.43 | -107.36 | 60.07 | -261.5 | -349.38 | -146.51 |
Change in Working Capital | -150.1 | -150.1 | 72.52 | -105.94 | -75.79 | -30.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.